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Abstract
Background: Ketogenic diets are an effective healthy way of losing weight since they promote a
non-atherogenic lipid profile, lower blood pressure and decrease resistance to insulin with an
improvement in blood levels of glucose and insulin. On the other hand, Mediterranean diet is well
known to be one of the healthiest diets, being the basic ingredients of such diet the olive oil, red
wine and vegetables. In Spain the fish is an important component of such diet. The objective of this
study was to determine the dietary effects of a protein ketogenic diet rich in olive oil, salad, fish
and red wine.
Methods: A prospective study was carried out in 31 obese subjects (22 male and 19 female) with
the inclusion criteria whose body mass index and age was 36.46 ± 2.22 and 38.48 ± 2.27,
respectively. This Ketogenic diet was called "Spanish Ketogenic Mediterranean Diet" (SKMD) due
to the incorporation of virgin olive oil as the principal source of fat (≥30 ml/day), moderate red
wine intake (200–400 ml/day), green vegetables and salads as the main source of carbohydrates and
fish as the main source of proteins. It was an unlimited calorie diet. Statistical differences between
the parameters studied before and after the administration of the "Spanish Ketogenic
Mediterranean diet" (week 0 and 12) were analyzed by paired Student's t test.
Results: There was an extremely significant (p < 0.0001) reduction in body weight (108.62 kg→
94.48 kg), body mass index (36.46 kg/m2→31.76 kg/m2), systolic blood pressure (125.71
mmHg→109.05 mmHg), diastolic blood pressure (84.52 mmHg→ 75.24 mmHg), total cholesterol
(208.24 mg/dl→186.62 mg/dl), triacylglicerols (218.67 mg/dl→113.90 mg/dl) and glucose (109.81
mg/dl→ 93.33 mg/dl). There was a significant (p = 0.0167) reduction in LDLc (114.52 mg/
dl→105.95 mg/dl) and an extremely significant increase in HDLc (50.10 mg/dl→54.57 mg/dl). The
most affected parameter was the triacylglicerols (47.91% of reduction).
Conclusion: The SKMD is safe, an effective way of losing weight, promoting non-atherogenic lipid
profiles, lowering blood pressure and improving fasting blood glucose levels. Future research
should include a larger sample size, a longer term use and a comparison with other ketogenic diets.
Published: 26 October 2008
Nutrition Journal 2008, 7:30 doi:10.1186/1475-2891-7-30
Received: 2 June 2008
Accepted: 26 October 2008
This article is available from: http://www.nutritionj.com/content/7/1/30
© 2008 Pérez-Guisado et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Nutrition Journal 2008, 7:30 http://www.nutritionj.com/content/7/1/30
Page 2 of 7
(page number not for citation purposes)
Background
The international consensus is that carbohydrates are the
basis of the food pyramid for a healthy diet and that the
best way to lose weight is by cutting back on calories
chiefly in the form of fat. It is generally believed that
ketogenic diets may lead to the development of several
diseases. However, many studies have found that
ketogenic diets are healthier since they help to preserve
muscle mass, reduce appetite, diminish metabolic effi-
ciency, induce metabolic activation of thermogenesis,
favor increased fat loss, promote a non-atherogenic lipid
profile, lower blood pressure and decrease resistance to
insulin with an improvement in blood levels of glucose
and insulin [1]. Contrary to past opinions, high carbohy-
drate diets may be associated with: low levels of high-den-
sity lipoprotein cholesterol (HDLc), high levels of
triacylglycerols (TG), low-density lipoprotein cholesterol
(LDLc) and total cholesterol [2], type 2 diabetes mellitus
[3], metabolic syndrome, essential hypertension [4] and
cancer [5].
Mediterranean diet has evident health benefits. Such diet
is associated with a longer life span [6,7] and lower rates
of coronary heart disease, certain cancers [8], hypercholes-
terolemia, hypertension, diabetes and obesity [9]. It is dif-
ficult to define which are the healthiest constituents of the
Mediterranean diet, since it is a very varied diet that can
change among the Mediterranean countries. For example,
in Spain the fish is an important component [10,11] as
well as the olive oil, red wine and vegetables, that are 3
essential components of such diet in all the countries. The
healthy properties of the incorporation of olive oil, red
wine and fish consumption to a ketogenic diet could be
explained by the 3 following sections. Regarding the
healthy properties of vegetables it is well known that they
are high in water, phytonutrients, antioxidants and pro-
vide a good source of fiber.
The objective of the present study was to determine the
dietary effects of the "Spanish Ketogenic Mediterranean
Diet" (SKMD). Such diet was a protein ketogenic diet
under free-living conditions with 4 important healthy
components of the Mediterranean diet in Spain: olive oil,
salad, fish and red wine. Therefore, the present study was
carried out to demonstrate the changes in body weight,
blood pressure, lipid profile and glucose that might occur
after the administration of SKMD throughout the period
of study (12 weeks), in healthy obese subjects.
Olive oil
Olive oil, is considered the pillar of the Mediterranean
diet, since it improves the major risk factors for cardiovas-
cular disease, such as the lipoprotein profile, blood pres-
sure, glucose metabolism and antithrombotic profile.
Endothelial function, inflammation and oxidative stress
are also positively modulated. Some of these effects are
attributed beside the monounsaturated fatty acids
(MUFA) to the minor components of virgin olive oil [12].
Hydrocarbons, polyphenols, tocopherols, sterols, triterpe-
noids and other components, despite their low concentra-
tion, non-fatty acid constituents may be of importance
because studies comparing monounsaturated dietary oils
have reported different effects on cardiovascular disease.
Most of these compounds have demonstrated antioxi-
dant, anti-inflammatory and hypolipidemic properties
[13]. Moreover, MUFA-rich diet prevents central fat redis-
tribution and the postprandial decrease in peripheral adi-
ponectin gene expression and insulin resistance induced
by a carbohydrate-rich diet in insulin-resistant subjects
[14].
Red wine
The combination of ethanol and phenolic compounds in
red wine is thought to be responsible for the apparent pro-
tective cardiovascular effect [15], showing olive oil and
red wine antioxidant polyphenols antiatherogenic prop-
erties [16]. Moreover, combined consumption of wine
and olive oil provided beneficial postprandial effects on
haemodynamics [17].
Fish
Two long-chain Omega-3 polyunsaturated fatty acids (n-
3 PUFA), eicosapentaenoic acid (EPA) and docosahexae-
noic acid (DHA), are the active constituents of the fish.
Low rates of death from coronary heart disease has been
report among individuals with very high consumption of
fish, although these people should limit intake of species
highest in mercury levels. Larger, longer-living predators
(swordfish, shark) have higher tissue concentrations,
while smaller or shorter-lived species (anchovy, shellfish,
salmon, sardine) have very low concentrations [18].
High omega-3 consumption increases insulin sensitivity
and reduces inflammatory markers [19] and Piers et al.
have hypothesized that unsaturated fats (MUFA and/or
PUFA), rather than saturated fat (SFA), are more effective
in stimulating peroxisome proliferator-activated receptor-
α leading to fat oxidation, with SFA being much more
readily diverted to fat storage [20].
Methods
Subjects
A prospective study was carried out at a General Medicine
Consultation (Córdoba, Spain) in 40 overweight subjects
(22 male and 19 female) whose body mass index and age
was 36.46 ± 2.22 and 38.48 ± 2.27, respectively. Subjects
were selected with the cooperation of a database medical
weight loss clinic. Inclusion criteria were: a diet based on
carbohydrate foods (> 50% of dairy energy intake),
achievement of desired weight loss, normal liver and renalNutrition Journal 2008, 7:30 http://www.nutritionj.com/content/7/1/30
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function, not to have antecedents of gout or high uric
acid, not to have exercise, alcoholic and smoking habits,
not to be pregnant or lactating, IMC ≥ 30, age ≥ 18 years
and ≤ 65 years and not to be under medication. Since
obesity increases the risk for alterations in hepatocyte
function that lead to accumulation of lipid in hepatocytes
and hepatomegaly (Non-alcoholic Fatty Liver Disease),
we consider higher liver transaminase levels as a variant of
normality in such obese patients (hepatic transaminases ≤
twice normal values → GOT and GPT ≤ 80 mU/ml).
Chronic hepatitis B or C was ruled out in such patients by
negative serologies. We determined normal renal function
as measured by plasma urea nitrogen and plasma creati-
nine: creatinine ≤ 1.3 mg/dl and urea ≤ 40 mg/dl. Subjects
with the inclusion criteria were selected for eligibility by
phone and 40 eligible subjects were invited to attend an
orientation session during the week prior to the study.
Patients measured their body's ketosis state every morning
by ketone strips. During the study, the participants were
phoned by the same person weekly, in order to assure the
correct realization of the protocol and the ketosis state. If
the subjects failed to maintain adequate compliance with
the clinical trial protocol they would be dropped out the
study.
Subjects received no monetary compensation for their
participation and provided voluntary written consent
form before initiating the diet.
The Ethics and Clinical Investigation Committee of the
"Spanish Medical Association of the Proteinic Diet"
approved the study protocol, informed consent form and
subject informational materials. Patient anonymity was
preserved.
Diet
This protein ketogenic diet was called "Spanish Ketogenic
Mediterranean Diet" (SKMD) due to the incorporation of
virgin olive oil as the principal source of fat, moderate red
wine intake, green vegetables and salads as the main
source of carbohydrates and fish as the main source of
proteins. It was an unlimited calorie diet, nevertheless
subjects were encouraged to consume per day: a maxi-
mum of 30 g of carbohydrates in the form of green vege-
tables and salad, a minimum of 30 ml of virgin olive oil,
200–400 ml of red wine and no limit of the protein block.
Participants were permitted 3 portions (200 g/portion) of
vegetables daily: 2 portions of salad vegetables (such as
alfalfa sprouts, lettuce, escarole, endive, mushrooms, rad-
icchio, radishes, parsley, peppers, chicory, spinach,
cucumber, chard and celery), and 1 portion of low-carbo-
hydrate vegetables (such as broccoli, cauliflower, cabbage,
artichoke, eggplant, squash, tomato and onion). 3 por-
tions of salad vegetables were allowed only if the portion
of low-carbohydrate vegetables were not consumed. Salad
dressing allowed were: garlic, olive oil, vinegar, lemon
juice, salt, herbs and spices.
The minimum 30 ml of olive oil were distributed unless
in 10 ml per principal meal (breakfast, lunch and dinner).
Red wine (200–400 ml a day) was distributed in 100–200
ml per lunch and dinner. The protein block was divided
in "fish block" and "no fish block". The "fish block"
included all the types of fish except larger, longer-living
predators (swordfish and shark). The "no fish block"
included meat, fowl, eggs, shellfish and cheese. Both pro-
tein blocks were not mixed in the same day and were con-
sumed individually during its day on the condition that at
least 4 days of the week were for the "fish block".
Trans fats (margarines and their derivatives) and proc-
essed meats with added sugar were not allowed.
No more than two cups of coffee or tea and at least 3 litres
of water were intake each day. Infusions and artificial
sweeteners were allowed (saccharin, cyclamate, acesul-
fame, aspartame and sucralose).
Supplements
Micronutrients (vitamins and minerals) were given daily
to each subject in the form of 2 tablets of a poly-vitamin-
mineral supplement and one tablet of calcium carbonate
1500 mg. Each tablet of the poly-vitamin-mineral supple-
ment contained: vitamin A 680 mcg, Beta-carotene 720
mcg, vitamin D 5 mcg, vitamin E 10 mg, vitamin C 60 mg,
vitamin B1 1.4 mg, vitamin B2 1.6 mg, vitamin B6 2 mg,
folic acid 200 mcg, vitamin B12 1 mcg, niacin 18 mg,
biotin 150 mcg, pantothenic acid 6 mg, vitamin K 30 mcg,
calcium 120 mg, potassium 40 mg, phosphorus 126.3
mcg, iron 8 mg, magnesium 45 mg, cupper 0.9 mg, zinc 8
mg, manganesum 1.8 mg, iodine 75 mcg, molibden 45
mcg, boron 70 mcg, chlorine 21 mg, chromium 25 mcg,
molybdenum 45 mcg, nickel 5 mcg, selenium 55 mcg, sil-
icon 3 mg, sin 10 mcg, vanadium 10 mcg.
Measurements
Subjects were weighed and systolic/diastolic blood pres-
sure was measurement at weeks 0, 4, 8 and 12, at the same
time (that depends on the subject) and using always the
same digital scale ("Seca 703") and mercurial sphyg-
momanometer ("Labtron Model 03-225").
Fasting venous blood samples were collected at weeks 0
and 12 for total cholesterol, HDLc, LDLc, triacylglycerol
and glucose. Venous blood samples for glucose, lipid and
lipoprotein analysis were collected into EDTA-containing
(1 g/l) tubes from all subjects after a 12 h overnight fast at
the beginning of the study and at the end of each dietary
period. Plasma was obtained by low-speed centrifugationNutrition Journal 2008, 7:30 http://www.nutritionj.com/content/7/1/30
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for 15 min at 4°C within 1 h of venepuncture. Plasma
cholesterol and TAG levels were determined by enzymatic
techniques. HDL-cholesterol was determined after precip-
itation with fosfowolframic acid LDL-cholesterol concen-
tration was calculated using the Friedewald formula.
Plasma glucose was measured by the glucose oxidase
method. To reduce interassay variation, plasma was stored
at -80°C and analysed at the end of the study.
Statistical analysis
Statistical differences between the parameters before and
after the administration of the SKMD (week 0 and 12)
were analyzed by paired Student's t test with SPSS 12.0
(SPSS Inc., Chicago, IL, USA) and are expressed as mean ±
standard error of the mean (SEM). The parameters studied
were: weight, body mass index (BMI), systolic blood pres-
sure (SBP), diastolic blood pressure (DBP), total choles-
terol, HDLc, LDLc, triacylglycerol and glucose. Before the
Student's t test, Kolmogorov-Smirnov and Shapiro-Wilk
tests were used for testing normality and the assumption




Of the 40 persons who started the study, data collected
from 31 subjects were used in the final analysis. Data were
not use from 9 subjects: 3 subjects were withdrawn for
failure to maintain adequate compliance with the clinical
trial protocol; 4 subjects were lost to follow-up; 1 subject
withdrew because he said the diet was too expensive; 1
subject was withdrawn due to suffer a polytraumatism car
accident.
Parameters analyzed
Normal distribution and the assumption of homoscedas-
ticity were verified. As there were no significant differences
in male and female subjects in all the parameters exam-
ined (p > 0.05), the data of males and females in each
group are pooled and presented together. The changes in
all the parameters studied are shown in Table 1.
There was an extremely significant (p < 0.0001) reduction
in body weight (108.62 kg→ 94.48 kg), BMI (36.46 kg/
m2→31.76 kg/m2), SBP (125.71 mmHg→109.05
mmHg), DBP (84.52 mmHg→ 75.24 mmHg), total cho-
lesterol (208.24 mg/dl→186.62 mg/dl) and glucose
(109.81 mg/dl→ 93.33 mg/dl). There was a significant (p
= 0.0167) reduction in LDLc (114.52 mg/dl→105.95 mg/




It is thought that consumption of a high-fat-protein diet
will be accompanied by a higher weight gain. On the con-
trary, our results confirm that the SKMD is an effective
therapy for obesity without caloric restriction. This might
be due to the fact that there is a synergic effect between the
high protein ketogenic nature of the diet and its richness
in MUFA and PUFA. We don't have data about the per-
centage of body fat and lean body mass lost. Nevertheless
we think that there was a more selective fat loss because
we didn't observe the flaccidity physical aspect that we
have observed before with hypocaloric diets, and subjects
had a physical aspect similar to a liposuction, since fat was
removed from many different fat specific deposit areas,
Table 1: Changes in the level of various parameters before and after the SKMD
Parameters Week 0* Week 12* % of Change P
Weight (kg) 108.62 ± 3.18 94.48 ± 2.83 13.02 <0.0001
BMI (kg/m2) 36.46 ± 0.84 31.76 ± 0.74 12.89 <0.0001
Total Cholesterol (mg/dl) 208.24 ± 5.86 186.62 ± 5.80 10.38 <0.0001
LDLc (mg/dl) 114.52 ± 6.17 105.95 ± 7.67 7.48 0.0167
HDLc (mg/dl) 50.10 ± 1.69 54.57 ± 1.50 8.19 <0.0001
Triacylglicerols (mg/dl) 218.67 ± 9.55 113.90 ± 5.20 47.91 <0.0001
Glycemia (mg/dl) 109.81 ± 2.22 93.33 ± 1.83 15.01 <0.0001
SBP (mm Hg) 125.71 ± 5.19 109.05 ± 4.41 13.25 <0.0001
DBP (mm Hg) 84.52 ± 2.76 75.24 ± 2.35 10.98 <0.0001
*Data are expressed as mean ± standard error of the mean (SEM).Nutrition Journal 2008, 7:30 http://www.nutritionj.com/content/7/1/30
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including the abdomen, thighs, hips, buttocks, waist, neck
and upper arms. Our hypothesis is founded in the follow-
ing statements:
1. Many studies have confirmed that the ketogenic diet is
an effective therapy for obesity [1,21-26]. In addition to
the fact that an equal number of calories are ingested,
ketogenic diets are more effective for achieving fat loss
than the conventional high-carbohydrate/low-fat diets
[1,26]. Low-carbohydrate diets have even proved to be
more effective than conventional diets for more selective
fat loss and conserving muscle mass [1,24-26], moreover,
several longer term studies have noted improvements in
body composition on a higher protein pattern despite
similar weight loss [27].
2. MUFA-rich diet prevents central fat redistribution [14].
3. High unsaturated fat diet is more effective to preserve
lean mass than a low fat diet or a low carbohydrate diet
[23]. Moreover, the PUFA from the fish, DHA and EPA
exhibit "anti-obesity" effect as well as improving insulin
sensitivity [28].
In connection with the moderate red wine consumption
of the SKMD, we agree with the statement that moderate
red wine consumption (450 ml) is not associated with dif-
ferences in body weight [29], so this consumption would
not affect to the weight loss.
Further trials are required to examine the potential role of
the SKMD for the selective fat loss and its protective effect
against muscle protein catabolism.
Glycemic control
During the SKMD the fasting glycemia improved signifi-
cantly. These findings could be explained by the following
points:
1. A low carbohydrate diet reduces fasting glucose levels,
even independently of the weight loss [30,31].
2. MUFA-rich diet prevents insulin resistance induced by
a carbohydrate-rich diet in insulin-resistant subjects [14].
3. DHA-EPA also improve insulin sensitivity [28].
Our data are not enough to state with precision if the
SKMD is the same or better than a conventional ketogenic
diet to improve glycemic control due to its higher content
in MUFA and DHA-EPA.
We think that the moderate prandial red wine consump-
tion of the SKMD did not have effect (beneficial or
adverse) on the glycemic control, since Gin et al. reported
that moderate prandial wine consumption has no adverse
effect on the glycemic control of diabetic patients, thus it
appears unnecessary to proscribe the consumption of red
wine in moderation with meals to diabetic patients [32].
Effects of the "Spanish Ketogenic Mediterranean diet" on 
cardiovascular parameters
The data presented in this study showed that the SKMD
significantly decreases the total cholesterol, LDLc, triacylg-
lycerols, SBP, DBP and increases the level of HDLc. This
healthy cardiovascular profile is probably due to the favo-
rable interaction of the weight loss and the components of
the SKMD: high protein ketogenic diet-virgin olive oil-fish
oil-red wine-salad. Our arguments are founded in the fol-
lowing findings:
1. Ketogenic diets improve all aspects of atherogenic dysl-
ipidemia, decreasing fasting and postprandial triglyceride
levels and increasing HDLc and LDLc particle size [1,33].
When the ketogenic diet is higher in protein than fat, the
level of LDLc also decreases [33-35].
2. Ingestion of virgin olive oil increases HDLc levels [36]
and decreases LDLc levels [37-39] and blood pressure
[38,39].
3. Omega-3 PUFA reduce plasma triacylglycerol concen-
trations [40,41].
4. Chronic moderate consumption of red wine (400 ml/
day) significantly reduces fasting LDLc and increases
HDLc in hypercholesterolaemic patients [42].
5. Low carbohydrate/high-protein diets are more effective
than high-carbohydrate diets for decreasing blood pres-
sure, both diastolic and systolic [43].
6. The salad consumption is inversely associated with
diastolic blood pressure [44].
Explanations and Suggestions
We recognize several limitations of our study that may
have influenced the study findings:
1. The sample of the study is small (31 subjects).
2. This is not a random population study, since subjects
were selected for eligibility and their eligibility was related
with their compliance to the diet.
3. Weight loss may be related with improvement in all
parameters that are studied.
4. We didn't take into consideration calories intake before
and after the 12 weeks. Although it is known that an equalNutrition Journal 2008, 7:30 http://www.nutritionj.com/content/7/1/30
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number of calories are ingested, ketogenic diets are more
effective for achieving fat loss than the conventional high-
carbohydrate/low-fat diets [1,26], we don't know if our
patients intake less food and calories, and if it is the case,
this would be correlated with weigh reduction and better
cardiovascular parameters.
5. Although the effect of vitamins is not clear, especially in
short interventions, their possible contribution to better
cardiovascular parameters should be possible.
6. Our study has no control groups to consider the inter-
action between the components of the SKMD. There is no
way to say if the healthy results are due to the ketogenic
nature of the diet, the virgin olive oil, the red wine, the
higher fish intake, the higher salad intake or a synergic
effect between these components.
All these limitations should be known and accordingly
considered by further trials.
Conclusion
The SKMD is safe, an effective way of losing weight, pro-
moting non-atherogenic lipid profiles, lowering blood
pressure and improving fasting blood glucose levels.
Future research should include a larger sample size, a
longer term use and a comparison with other ketogenic
diets.
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